United Therapeutics (UTHR) Cost of Revenue (2009 - 2026)
United Therapeutics (UTHR) posted Cost of Revenue of $133.4 million for Q1 2026, up 29.01% sequentially from $103.4 million in Q4 2025, and up 44.22% YoY from $92.5 million in Q1 2025.
United Therapeutics (UTHR) Cost of Revenue (2009 - 2026) Analysis & Trends
United Therapeutics has reported Cost of Revenue for 18 years, with the latest figure at $133.4 million in Q1 2026.
- Quarterly Cost of Revenue rose 44.22% year-over-year to $133.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $425.3 million (up 29.15% YoY) and the FY2025 annual result came in at $384.4 million, up 24.12% from the prior year.
- Cost of Revenue improved to $133.4 million in Q1 2026 per UTHR's latest filing, from $103.4 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $133.4 million in Q1 2026 and troughed at $25.9 million in Q1 2022.
- A 5-year average of $72.7 million and a median of $72.9 million in 2024 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2022 and 2023: Cost of Revenue declined 20.16% in 2022, then soared 115.82% in 2023.
- Over 5 years, Cost of Revenue stood at $58.8 million in 2022, then advanced by 20.75% to $71.0 million in 2023, then grew by 6.9% to $75.9 million in 2024, then jumped by 36.23% to $103.4 million in 2025, then rose by 29.01% to $133.4 million in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $133.4 million, $103.4 million, and $100.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn | 98.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 99.50 Mn |
| Jun 30, 2026 | 99.50 Mn |
| Mar 31, 2026 | 133.40 Mn |
| Mar 31, 2026 | 133.40 Mn |
| Dec 31, 2025 | 103.40 Mn |
| Dec 31, 2025 | 103.40 Mn |
| Sep 30, 2025 | 100.90 Mn |
| Sep 30, 2025 | 100.90 Mn |
| Jun 30, 2025 | 87.60 Mn |
| Jun 30, 2025 | 87.60 Mn |
| Mar 31, 2025 | 92.50 Mn |
| Mar 31, 2025 | 92.50 Mn |
| Dec 31, 2024 | 75.90 Mn |
| Dec 31, 2024 | 75.90 Mn |
| Sep 30, 2024 | 83.10 Mn |
| Sep 30, 2024 | 83.10 Mn |
| Jun 30, 2024 | 77.80 Mn |
| Jun 30, 2024 | 77.80 Mn |
| Mar 31, 2024 | 72.90 Mn |
| Mar 31, 2024 | 72.90 Mn |